OBJECTIVE: @entity4048 is a highly prevalent condition, and is often treated with non-steroidal anti-inflammatory drugs. Limited clinical studies with short-term follow-up have shown promising efficacy of acupuncture as well as miniscalpel-needle (MSN) release. In this retrospective study, we examined whether MSN release could produce long-lasting relief in @entity1 with @entity4048 . METHODS: We retrieved the medical records of all @entity1 receiving weekly MSN release treatment for @entity4048 at this institution during a period from May 2012 to December 2013. Only cases with the following information at prior to, and 1, 6, and 12 months after the treatment, were included in the analysis: @entity717 ( @entity717 ), numerical @entity158 rating scale (NPRS), and active cervical range of motion (CROM). The primary analysis of interest is comparison of the 12-month measures with the baseline. @entity1 who took analgesic drugs or massage within 2 weeks prior to assessment were excluded from the analysis. For MSN release, tender points were identified manually by an experienced physician, and did not necessarily follow the traditional acupuncture system. MSN was inserted vertically (parallel to the spine) until breaking through resistance and @entity1 reporting of distention, soreness or @entity11728 . The depth of the needling ranged from 10 to 50 mm. The release was carried out by moving the MSN up and down 3-5 times without rotation. RESULTS: A total of 559 cases ( @entity1 receiving weekly MSN release treatment for @entity4048 ) were screened. The number of cases with complete information ( @entity717 , NPRS, and CROM at baseline, 1, 6 and 12 months after last treatment) was 180. After excluding the cases with analgesic treatment or massage within 2 weeks of assessment (n = 53), a total of 127 cases were included in data analysis. The number of MSN release session was 7 (range: 4-11). At 12 months after the treatment, both NPRS and @entity717 were significantly lower [3 (0, 9) vs. 7 (5, 10) at the baseline for NPRS; [7 (0, 21) vs. 17 (9, 36) for @entity717 ; p<0.001 for both]. All 6 measures of CROM were significantly higher at 12 months vs. the baseline. No severe complications (such as @entity16 and @entity1410 ) were noted. DISCUSSION: MSN release is effective, even 12 months after the treatment, in @entity1 with @entity4048 . Caution must be exercised in data interpretation due to the respective nature of the study and lack of a comparator group.

Effects of Miniscalpel-Needle Release on XXXX : A Retrospective Analysis with 12-Month Follow-Up.

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients', 'patient'] @entity16 :: ('MESH:D009422', 'Disease') :: ['nerve damage'] @entity11728 :: ('MESH:D006362', 'Disease') :: ['heaviness'] @entity4048 :: ('MESH:D019547', 'Disease') :: ['chronic neck pain', 'Chronic neck pain'] @entity1410 :: ('MESH:D006406', 'Disease') :: ['hematoma'] @entity158 :: ('MESH:D010146', 'Disease') :: ['pain'] @entity717 :: ('MESH:D009069', 'Disease') :: ['NDI', 'neck disability index']
@entity4048 :: (MESH:D019547,Disease) :: ['Chronic Neck Pain']
